Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000093751-25-000277·HALOZYME THERAPEUTICS, INC.
Schedule 13G ownership disclosure
Halozyme Therapeutics Inc
COMMON STOCK · CUSIP: 40637H109
Event date: 2025-03-31
- Filing-level shares
- 6,053,007.00
- Percent of class
- 4.9%
- STATE STREET CORPORATION
Shares: 6,053,007.00 · Class: 4.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000093751-25-000277
- Form type
- SCHEDULE 13G
- Filer
- HALOZYME THERAPEUTICS, INC.
- CIK
- CIK 1159036
- Filed
- May 13, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership